Immunotherapy CD Protein Inhibitors Immune Checkpoint Inhibitors Tyrosine Kinase Inhibitors PARP Inhibitors | Solid Tumor | HER2 Positive Breast Cancer | Pancreatic Adenocarcinoma | Pancreatic Ductal Adenocarcinoma | Colorectal Cancer | Prostate Cancer | Gastric Cancer |
---|---|---|---|---|---|---|---|
nivolumab + ipilimumab | |||||||
pucotenlimab | |||||||
atezolizumab | |||||||
avelumab | |||||||
pembrolizumab + trastuzumab | |||||||
pembrolizumab | |||||||
olaparib | |||||||
Immunotherapy |